CLINICAL_TRIALS
trial_result
· 2008-07-03
Clinical Trial Update: Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease [Phase 3]
Summary
Phase 3 safety and efficacy study of PB127 Ultrasound Contrast Agent in patients with suspected coronary artery disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Point Biomedical | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED